{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-22-000118","form_type":"8-K","ticker":"NTRB","cik":"0001676047","company_name":"NutriBand Inc.","filed_at":"2022-01-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.764572+00:00","generated_at":"2026-06-27T21:25:31.821561+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Nutriband receives Korean patent for abuse-deterrent transdermal system AVERSA","bullets":["Korean Intellectual Property Office issued full patent titled 'Abuse and Misuse Deterrent Transdermal System'.","Patent supports 4p Therapeutics' AVERSA fentanyl transdermal system using taste aversion.","Company previously received notice of allowance in December 2020."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-22-000118","json":"https://secwatch.observer/filing/0001213900-22-000118.json","markdown":"https://secwatch.observer/filing/0001213900-22-000118.md","text":"https://secwatch.observer/filing/0001213900-22-000118.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/0001213900-22-000118-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676047/000121390022000118/ea153351-8k_nutribandinc.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T21:25:31.821561+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}